1. Home
  2. FOFO vs LPCN Comparison

FOFO vs LPCN Comparison

Compare FOFO & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

FOFO

Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

N/A

Current Price

$2.70

Market Cap

19.2M

Sector

N/A

ML Signal

N/A

Logo Lipocine Inc.

LPCN

Lipocine Inc.

N/A

Current Price

$2.05

Market Cap

19.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FOFO
LPCN
Founded
2017
1997
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.2M
19.1M
IPO Year
2025
2011

Fundamental Metrics

Financial Performance
Metric
FOFO
LPCN
Price
$2.70
$2.05
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
19.0K
39.7K
Earning Date
03-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,976,677.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$92.00
P/E Ratio
$11.09
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.75
$1.81
52 Week High
$68.00
$12.37

Technical Indicators

Market Signals
Indicator
FOFO
LPCN
Relative Strength Index (RSI) 52.83 41.67
Support Level $2.33 $1.99
Resistance Level $2.88 $2.30
Average True Range (ATR) 0.19 0.12
MACD 0.06 0.00
Stochastic Oscillator 77.36 29.11

Price Performance

Historical Comparison
FOFO
LPCN

About FOFO Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their business and investment objectives. Its business consists of two main business lines: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting and Regulatory compliance and governance consulting, and the asset management services, including fund subscription and fund management services.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: